| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intra-Abdominal Fat | 57 | 2017 | 625 | 10.990 |
Why?
|
| Subcutaneous Fat | 30 | 2016 | 404 | 5.740 |
Why?
|
| Albuminuria | 33 | 2017 | 658 | 4.830 |
Why?
|
| Adiposity | 43 | 2018 | 1895 | 4.710 |
Why?
|
| Body Fat Distribution | 18 | 2019 | 246 | 4.170 |
Why?
|
| Cardiovascular Diseases | 118 | 2018 | 15661 | 4.170 |
Why?
|
| Subcutaneous Fat, Abdominal | 13 | 2015 | 91 | 3.730 |
Why?
|
| Glomerular Filtration Rate | 53 | 2017 | 2228 | 3.640 |
Why?
|
| Kidney Failure, Chronic | 29 | 2013 | 2493 | 3.370 |
Why?
|
| Obesity | 97 | 2018 | 13091 | 3.120 |
Why?
|
| Renal Insufficiency, Chronic | 32 | 2017 | 2297 | 3.020 |
Why?
|
| Polymorphism, Single Nucleotide | 115 | 2021 | 16053 | 2.470 |
Why?
|
| Calcinosis | 31 | 2018 | 1479 | 2.470 |
Why?
|
| Kidney Diseases | 24 | 2017 | 2100 | 2.460 |
Why?
|
| Genome-Wide Association Study | 105 | 2022 | 12801 | 2.410 |
Why?
|
| Obesity, Abdominal | 9 | 2015 | 375 | 2.110 |
Why?
|
| Body Mass Index | 99 | 2019 | 13055 | 2.100 |
Why?
|
| Abdominal Fat | 10 | 2016 | 221 | 2.050 |
Why?
|
| Genetic Loci | 27 | 2017 | 2630 | 1.680 |
Why?
|
| Middle Aged | 348 | 2019 | 223737 | 1.630 |
Why?
|
| Risk Factors | 191 | 2019 | 74976 | 1.610 |
Why?
|
| Kidney | 21 | 2017 | 7058 | 1.590 |
Why?
|
| Adipose Tissue | 23 | 2017 | 3335 | 1.570 |
Why?
|
| Genome, Human | 30 | 2017 | 4456 | 1.560 |
Why?
|
| Diabetes Mellitus, Type 2 | 63 | 2017 | 12253 | 1.480 |
Why?
|
| Aorta, Abdominal | 11 | 2017 | 627 | 1.440 |
Why?
|
| Male | 379 | 2021 | 365203 | 1.350 |
Why?
|
| Genetic Predisposition to Disease | 64 | 2019 | 18068 | 1.340 |
Why?
|
| Neck | 5 | 2016 | 736 | 1.320 |
Why?
|
| Genetic Linkage | 16 | 2011 | 2342 | 1.320 |
Why?
|
| Diabetes Mellitus | 30 | 2017 | 5892 | 1.300 |
Why?
|
| Fatty Liver | 8 | 2017 | 810 | 1.290 |
Why?
|
| Waist Circumference | 26 | 2017 | 935 | 1.290 |
Why?
|
| Female | 387 | 2021 | 397515 | 1.290 |
Why?
|
| Cystatin C | 11 | 2013 | 272 | 1.260 |
Why?
|
| Insulin Resistance | 36 | 2016 | 3982 | 1.220 |
Why?
|
| Aspartate Aminotransferases | 4 | 2016 | 414 | 1.210 |
Why?
|
| Aortic Diseases | 11 | 2017 | 741 | 1.210 |
Why?
|
| Cohort Studies | 116 | 2018 | 41808 | 1.190 |
Why?
|
| American Heart Association | 14 | 2015 | 1051 | 1.180 |
Why?
|
| Creatinine | 22 | 2016 | 1917 | 1.170 |
Why?
|
| Blood Glucose | 37 | 2016 | 6435 | 1.110 |
Why?
|
| Genetic Variation | 28 | 2019 | 6611 | 1.110 |
Why?
|
| Humans | 485 | 2022 | 768970 | 1.060 |
Why?
|
| Diabetic Angiopathies | 8 | 2014 | 806 | 1.040 |
Why?
|
| Adult | 226 | 2019 | 223851 | 1.020 |
Why?
|
| Diabetes Complications | 13 | 2013 | 1320 | 1.010 |
Why?
|
| Massachusetts | 50 | 2017 | 8894 | 1.000 |
Why?
|
| Incidence | 65 | 2018 | 21547 | 0.970 |
Why?
|
| Aged | 194 | 2018 | 171786 | 0.960 |
Why?
|
| Weight Gain | 10 | 2015 | 2359 | 0.950 |
Why?
|
| Uromodulin | 7 | 2014 | 48 | 0.920 |
Why?
|
| Hypertension | 32 | 2017 | 8617 | 0.900 |
Why?
|
| Heart Diseases | 13 | 2016 | 2819 | 0.890 |
Why?
|
| Pericardium | 12 | 2016 | 679 | 0.880 |
Why?
|
| Coronary Artery Disease | 23 | 2018 | 6569 | 0.880 |
Why?
|
| Periodicals as Topic | 4 | 2016 | 1470 | 0.870 |
Why?
|
| Alanine Transaminase | 3 | 2016 | 606 | 0.870 |
Why?
|
| Polymorphism, Genetic | 11 | 2016 | 4251 | 0.870 |
Why?
|
| Journal Impact Factor | 2 | 2015 | 156 | 0.860 |
Why?
|
| Uric Acid | 7 | 2014 | 806 | 0.850 |
Why?
|
| Cross-Sectional Studies | 57 | 2022 | 26395 | 0.850 |
Why?
|
| Multivariate Analysis | 34 | 2016 | 12095 | 0.830 |
Why?
|
| Aorta, Thoracic | 7 | 2018 | 1112 | 0.830 |
Why?
|
| Prediabetic State | 6 | 2016 | 548 | 0.800 |
Why?
|
| Odds Ratio | 30 | 2017 | 9684 | 0.800 |
Why?
|
| Phosphorus | 4 | 2011 | 336 | 0.790 |
Why?
|
| Fasting | 15 | 2016 | 1610 | 0.780 |
Why?
|
| Prevalence | 53 | 2018 | 15879 | 0.780 |
Why?
|
| Logistic Models | 34 | 2017 | 13318 | 0.770 |
Why?
|
| Linear Models | 23 | 2017 | 5891 | 0.770 |
Why?
|
| Sweetening Agents | 5 | 2016 | 290 | 0.750 |
Why?
|
| Kidney Function Tests | 12 | 2017 | 684 | 0.750 |
Why?
|
| Insulin | 27 | 2016 | 6610 | 0.740 |
Why?
|
| Coronary Disease | 18 | 2015 | 5919 | 0.740 |
Why?
|
| Risk Assessment | 44 | 2018 | 24333 | 0.730 |
Why?
|
| Ankle Brachial Index | 2 | 2012 | 163 | 0.720 |
Why?
|
| Waist-Hip Ratio | 15 | 2019 | 520 | 0.710 |
Why?
|
| Genotype | 46 | 2017 | 13048 | 0.680 |
Why?
|
| Longitudinal Studies | 35 | 2019 | 14794 | 0.680 |
Why?
|
| Tomography, X-Ray Computed | 48 | 2018 | 20776 | 0.670 |
Why?
|
| Mucoproteins | 2 | 2009 | 49 | 0.670 |
Why?
|
| Body Size | 7 | 2016 | 463 | 0.650 |
Why?
|
| Body Height | 13 | 2021 | 1569 | 0.640 |
Why?
|
| Genetic Markers | 10 | 2017 | 2604 | 0.630 |
Why?
|
| Adiponectin | 9 | 2016 | 1117 | 0.620 |
Why?
|
| Quantitative Trait Loci | 18 | 2017 | 2133 | 0.600 |
Why?
|
| Amino Acid Transport Systems, Basic | 2 | 2017 | 35 | 0.590 |
Why?
|
| Phenotype | 43 | 2017 | 16731 | 0.590 |
Why?
|
| Beverages | 4 | 2016 | 819 | 0.590 |
Why?
|
| Diabetic Nephropathies | 5 | 2015 | 973 | 0.590 |
Why?
|
| Gout | 6 | 2012 | 621 | 0.580 |
Why?
|
| Primary Prevention | 2 | 2015 | 1187 | 0.580 |
Why?
|
| Thyroid Gland | 3 | 2016 | 1171 | 0.580 |
Why?
|
| Blood Pressure | 26 | 2015 | 8544 | 0.570 |
Why?
|
| Receptors, Cell Surface | 5 | 2015 | 2820 | 0.570 |
Why?
|
| Adipokines | 2 | 2017 | 309 | 0.570 |
Why?
|
| Sex Factors | 26 | 2015 | 10633 | 0.570 |
Why?
|
| Resistin | 5 | 2012 | 172 | 0.570 |
Why?
|
| Follow-Up Studies | 57 | 2018 | 39394 | 0.560 |
Why?
|
| Motor Activity | 9 | 2016 | 2713 | 0.560 |
Why?
|
| Body Weight | 14 | 2015 | 4628 | 0.550 |
Why?
|
| Cause of Death | 8 | 2017 | 3721 | 0.550 |
Why?
|
| Proportional Hazards Models | 32 | 2017 | 12562 | 0.540 |
Why?
|
| Anthropometry | 9 | 2016 | 1345 | 0.520 |
Why?
|
| Proinsulin | 3 | 2011 | 135 | 0.510 |
Why?
|
| Iodide Peroxidase | 2 | 2008 | 295 | 0.510 |
Why?
|
| Overweight | 10 | 2014 | 2448 | 0.500 |
Why?
|
| Internet | 3 | 2016 | 3112 | 0.490 |
Why?
|
| Dyslipidemias | 7 | 2016 | 873 | 0.490 |
Why?
|
| Thyrotropin | 5 | 2016 | 834 | 0.490 |
Why?
|
| Coronary Vessels | 12 | 2018 | 3124 | 0.490 |
Why?
|
| Predictive Value of Tests | 24 | 2018 | 15471 | 0.480 |
Why?
|
| Gene Frequency | 20 | 2019 | 3626 | 0.470 |
Why?
|
| Population Surveillance | 4 | 2016 | 2597 | 0.470 |
Why?
|
| Atherosclerosis | 13 | 2018 | 3431 | 0.460 |
Why?
|
| Electronic Mail | 1 | 2016 | 215 | 0.460 |
Why?
|
| Heart Valve Diseases | 4 | 2018 | 1030 | 0.460 |
Why?
|
| Sex Characteristics | 11 | 2015 | 2649 | 0.460 |
Why?
|
| United States | 67 | 2018 | 73186 | 0.460 |
Why?
|
| Cystatins | 3 | 2008 | 55 | 0.450 |
Why?
|
| Alleles | 16 | 2016 | 6901 | 0.450 |
Why?
|
| Prospective Studies | 46 | 2018 | 54962 | 0.450 |
Why?
|
| Marketing | 1 | 2016 | 224 | 0.450 |
Why?
|
| Homocysteine | 2 | 2015 | 637 | 0.450 |
Why?
|
| Prolactin | 1 | 2016 | 627 | 0.440 |
Why?
|
| Sex Distribution | 11 | 2015 | 2280 | 0.440 |
Why?
|
| Renal Insufficiency | 3 | 2015 | 812 | 0.430 |
Why?
|
| Chromosome Mapping | 11 | 2015 | 4625 | 0.430 |
Why?
|
| Body Composition | 4 | 2012 | 2462 | 0.430 |
Why?
|
| Triglycerides | 12 | 2014 | 2464 | 0.420 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2013 | 489 | 0.420 |
Why?
|
| Models, Genetic | 8 | 2016 | 3449 | 0.420 |
Why?
|
| Severity of Illness Index | 18 | 2015 | 15951 | 0.410 |
Why?
|
| Myocardial Infarction | 10 | 2017 | 11521 | 0.400 |
Why?
|
| Stroke | 16 | 2017 | 9756 | 0.400 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 7148 | 0.400 |
Why?
|
| Vitamin K 1 | 1 | 2012 | 47 | 0.400 |
Why?
|
| Cholesterol, HDL | 15 | 2014 | 1820 | 0.400 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2011 | 104 | 0.400 |
Why?
|
| Transaminases | 2 | 2012 | 199 | 0.390 |
Why?
|
| Bulimia | 1 | 2014 | 405 | 0.390 |
Why?
|
| Renal Artery | 1 | 2013 | 353 | 0.390 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 529 | 0.390 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2013 | 199 | 0.380 |
Why?
|
| Metabolic Diseases | 2 | 2016 | 684 | 0.380 |
Why?
|
| Galectin 3 | 1 | 2013 | 240 | 0.380 |
Why?
|
| Hyperglycemia | 4 | 2008 | 1389 | 0.380 |
Why?
|
| Amino Acids | 2 | 2017 | 1716 | 0.370 |
Why?
|
| Comorbidity | 18 | 2016 | 10592 | 0.370 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 590 | 0.370 |
Why?
|
| Epidemiologic Studies | 2 | 2016 | 677 | 0.370 |
Why?
|
| Tunica Intima | 6 | 2007 | 459 | 0.370 |
Why?
|
| Actigraphy | 1 | 2015 | 527 | 0.360 |
Why?
|
| Age Distribution | 11 | 2015 | 2875 | 0.360 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 91 | 0.360 |
Why?
|
| Proteins | 7 | 2019 | 6011 | 0.360 |
Why?
|
| Sarcopenia | 1 | 2016 | 377 | 0.360 |
Why?
|
| Diet | 9 | 2016 | 8088 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2014 | 3447 | 0.360 |
Why?
|
| Angiopoietin-2 | 1 | 2011 | 186 | 0.350 |
Why?
|
| Carotid Artery Diseases | 4 | 2006 | 878 | 0.350 |
Why?
|
| Adipocytes | 2 | 2016 | 1199 | 0.350 |
Why?
|
| Risk | 16 | 2015 | 9621 | 0.350 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2011 | 269 | 0.350 |
Why?
|
| Sodium | 4 | 2017 | 1597 | 0.350 |
Why?
|
| Zebrafish | 6 | 2016 | 3037 | 0.350 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.340 |
Why?
|
| Food Handling | 1 | 2010 | 158 | 0.340 |
Why?
|
| Chromosomes, Human | 4 | 2013 | 438 | 0.340 |
Why?
|
| Indians, North American | 5 | 2000 | 354 | 0.330 |
Why?
|
| Aged, 80 and over | 46 | 2017 | 59739 | 0.330 |
Why?
|
| Metabolome | 6 | 2016 | 1009 | 0.330 |
Why?
|
| Time Factors | 28 | 2017 | 40261 | 0.330 |
Why?
|
| Aldosterone | 5 | 2015 | 881 | 0.320 |
Why?
|
| Carbohydrates | 3 | 2016 | 389 | 0.320 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.320 |
Why?
|
| Angiography | 2 | 2015 | 1598 | 0.320 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 2008 | 26 | 0.320 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 2008 | 69 | 0.320 |
Why?
|
| Life Style | 11 | 2015 | 3931 | 0.320 |
Why?
|
| Prognosis | 24 | 2018 | 30046 | 0.320 |
Why?
|
| Hyperuricemia | 2 | 2009 | 223 | 0.320 |
Why?
|
| Troponin I | 1 | 2013 | 662 | 0.310 |
Why?
|
| Dementia | 2 | 2014 | 2741 | 0.310 |
Why?
|
| Cardiovascular System | 2 | 2013 | 841 | 0.310 |
Why?
|
| Sequence Analysis, DNA | 6 | 2014 | 4785 | 0.310 |
Why?
|
| Brachial Artery | 5 | 2013 | 373 | 0.300 |
Why?
|
| Age Factors | 21 | 2016 | 18435 | 0.300 |
Why?
|
| Reproduction | 1 | 2012 | 646 | 0.300 |
Why?
|
| Amidohydrolases | 1 | 2009 | 160 | 0.300 |
Why?
|
| Intermittent Claudication | 1 | 2010 | 305 | 0.300 |
Why?
|
| Case-Control Studies | 23 | 2019 | 22296 | 0.290 |
Why?
|
| Hospital Mortality | 3 | 2011 | 5369 | 0.290 |
Why?
|
| Carotid Artery, Common | 3 | 2006 | 175 | 0.290 |
Why?
|
| Organ Size | 8 | 2015 | 2268 | 0.290 |
Why?
|
| Peptides | 3 | 2014 | 4353 | 0.280 |
Why?
|
| Inflammation | 8 | 2014 | 10868 | 0.280 |
Why?
|
| Aortography | 5 | 2018 | 422 | 0.280 |
Why?
|
| Hypercholesterolemia | 4 | 2010 | 1145 | 0.280 |
Why?
|
| Reference Values | 11 | 2013 | 4940 | 0.280 |
Why?
|
| Lipids | 7 | 2019 | 3345 | 0.280 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2010 | 856 | 0.280 |
Why?
|
| Mitral Valve | 3 | 2016 | 1475 | 0.270 |
Why?
|
| Atrial Fibrillation | 8 | 2016 | 5176 | 0.270 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 2008 | 0.270 |
Why?
|
| Tomography, Spiral Computed | 2 | 2007 | 274 | 0.270 |
Why?
|
| Infertility, Female | 1 | 2012 | 764 | 0.270 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2005 | 1568 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2013 | 2893 | 0.260 |
Why?
|
| Meta-Analysis as Topic | 14 | 2013 | 1364 | 0.260 |
Why?
|
| Registries | 4 | 2011 | 8384 | 0.260 |
Why?
|
| Calcium | 8 | 2017 | 5792 | 0.260 |
Why?
|
| Regression Analysis | 12 | 2014 | 6346 | 0.260 |
Why?
|
| Hyperlipidemias | 3 | 2015 | 773 | 0.260 |
Why?
|
| Wrist | 1 | 2007 | 231 | 0.260 |
Why?
|
| Patient Compliance | 1 | 2016 | 2701 | 0.250 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 1962 | 0.250 |
Why?
|
| Smoking | 13 | 2017 | 9094 | 0.250 |
Why?
|
| Carotid Artery, Internal | 3 | 2006 | 445 | 0.250 |
Why?
|
| Endothelium, Vascular | 5 | 2015 | 4428 | 0.250 |
Why?
|
| Abdomen | 3 | 2009 | 1137 | 0.250 |
Why?
|
| C-Reactive Protein | 12 | 2013 | 3859 | 0.250 |
Why?
|
| Quantitative Trait, Heritable | 5 | 2010 | 540 | 0.250 |
Why?
|
| Alanine | 1 | 2008 | 614 | 0.240 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 581 | 0.240 |
Why?
|
| Yogurt | 3 | 2015 | 71 | 0.240 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 4978 | 0.240 |
Why?
|
| Energy Intake | 8 | 2016 | 2146 | 0.240 |
Why?
|
| Genomics | 5 | 2015 | 5928 | 0.240 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2011 | 1679 | 0.230 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 1936 | 0.230 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2011 | 2145 | 0.230 |
Why?
|
| Information Storage and Retrieval | 1 | 2010 | 831 | 0.230 |
Why?
|
| Radiography | 9 | 2015 | 6991 | 0.230 |
Why?
|
| Death Certificates | 1 | 2005 | 172 | 0.230 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2010 | 144 | 0.230 |
Why?
|
| Disease Progression | 14 | 2018 | 13674 | 0.230 |
Why?
|
| Thoracic Cavity | 2 | 2016 | 12 | 0.230 |
Why?
|
| Liver | 9 | 2017 | 7578 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2006 | 370 | 0.220 |
Why?
|
| Parents | 5 | 2014 | 3597 | 0.220 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1196 | 0.220 |
Why?
|
| Fetofetal Transfusion | 1 | 2005 | 117 | 0.220 |
Why?
|
| Aortic Valve | 4 | 2018 | 1969 | 0.220 |
Why?
|
| Weight Loss | 3 | 2013 | 2721 | 0.220 |
Why?
|
| Aorta | 2 | 2017 | 2046 | 0.220 |
Why?
|
| Gene Expression Regulation | 11 | 2017 | 11932 | 0.220 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 210 | 0.210 |
Why?
|
| Homeostasis | 8 | 2019 | 3347 | 0.210 |
Why?
|
| Nutrition Surveys | 6 | 2015 | 1738 | 0.210 |
Why?
|
| Glucose Intolerance | 6 | 2010 | 579 | 0.210 |
Why?
|
| Carotid Arteries | 2 | 2009 | 943 | 0.210 |
Why?
|
| Metabolomics | 4 | 2017 | 1675 | 0.210 |
Why?
|
| Dietary Sucrose | 2 | 2015 | 242 | 0.210 |
Why?
|
| Lod Score | 5 | 2007 | 600 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7460 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2004 | 432 | 0.200 |
Why?
|
| DNA | 3 | 2013 | 7214 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 3810 | 0.200 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 83 | 0.200 |
Why?
|
| Cognition Disorders | 1 | 2016 | 3985 | 0.190 |
Why?
|
| Renal Replacement Therapy | 1 | 2004 | 282 | 0.190 |
Why?
|
| Chronic Disease | 11 | 2011 | 9384 | 0.190 |
Why?
|
| Mitral Valve Stenosis | 1 | 2004 | 342 | 0.190 |
Why?
|
| Vitamin D | 3 | 2012 | 3311 | 0.190 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 3709 | 0.190 |
Why?
|
| Carrier Proteins | 2 | 2014 | 4939 | 0.190 |
Why?
|
| Blood Coagulation Factors | 1 | 2004 | 371 | 0.190 |
Why?
|
| Confidence Intervals | 6 | 2012 | 2932 | 0.190 |
Why?
|
| Cognition | 2 | 2016 | 7081 | 0.190 |
Why?
|
| Menopause | 4 | 2013 | 1656 | 0.190 |
Why?
|
| Haplotypes | 5 | 2010 | 2725 | 0.190 |
Why?
|
| Reproducibility of Results | 16 | 2017 | 20245 | 0.190 |
Why?
|
| Thyroxine | 2 | 2016 | 665 | 0.180 |
Why?
|
| Coronary Angiography | 10 | 2018 | 4541 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 1608 | 0.180 |
Why?
|
| Dairy Products | 2 | 2015 | 490 | 0.180 |
Why?
|
| Models, Statistical | 5 | 2014 | 5110 | 0.180 |
Why?
|
| Health Surveys | 9 | 2013 | 4055 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 3518 | 0.180 |
Why?
|
| Genetic Research | 2 | 2013 | 173 | 0.180 |
Why?
|
| Mississippi | 4 | 2015 | 94 | 0.180 |
Why?
|
| Observer Variation | 5 | 2014 | 2623 | 0.180 |
Why?
|
| Forecasting | 3 | 2017 | 2945 | 0.180 |
Why?
|
| Research Report | 3 | 2014 | 369 | 0.180 |
Why?
|
| Genetic Association Studies | 5 | 2014 | 2748 | 0.180 |
Why?
|
| Aging | 8 | 2016 | 8745 | 0.180 |
Why?
|
| Europe | 7 | 2021 | 3441 | 0.170 |
Why?
|
| Algorithms | 7 | 2012 | 14201 | 0.170 |
Why?
|
| Feeding Behavior | 6 | 2015 | 3205 | 0.170 |
Why?
|
| Natriuretic Peptides | 2 | 2011 | 156 | 0.170 |
Why?
|
| Molecular Motor Proteins | 2 | 2011 | 106 | 0.170 |
Why?
|
| Sensitivity and Specificity | 11 | 2017 | 14752 | 0.170 |
Why?
|
| TCF Transcription Factors | 3 | 2010 | 138 | 0.170 |
Why?
|
| Oxidative Stress | 3 | 2009 | 3139 | 0.170 |
Why?
|
| Retrospective Studies | 24 | 2017 | 81903 | 0.170 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 3438 | 0.170 |
Why?
|
| Vasodilation | 3 | 2009 | 967 | 0.170 |
Why?
|
| Hypertriglyceridemia | 3 | 2014 | 293 | 0.160 |
Why?
|
| Leptin | 4 | 2016 | 1597 | 0.160 |
Why?
|
| Cytokines | 2 | 2012 | 7453 | 0.160 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2012 | 205 | 0.160 |
Why?
|
| Apolipoprotein C-III | 2 | 2014 | 210 | 0.160 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2015 | 407 | 0.160 |
Why?
|
| Analysis of Variance | 6 | 2014 | 6236 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11684 | 0.160 |
Why?
|
| Air Pollutants | 3 | 2017 | 2915 | 0.160 |
Why?
|
| Glucose | 5 | 2017 | 4352 | 0.160 |
Why?
|
| Cardiology | 3 | 2015 | 1701 | 0.160 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2010 | 320 | 0.160 |
Why?
|
| Myosin Heavy Chains | 2 | 2011 | 404 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2012 | 800 | 0.150 |
Why?
|
| Probability | 6 | 2013 | 2483 | 0.150 |
Why?
|
| Family Health | 4 | 2017 | 1255 | 0.150 |
Why?
|
| Hypothyroidism | 2 | 2013 | 667 | 0.150 |
Why?
|
| Erythrocytes | 3 | 2016 | 2421 | 0.150 |
Why?
|
| Leukocyte Count | 2 | 2013 | 1609 | 0.150 |
Why?
|
| Games, Experimental | 1 | 2017 | 32 | 0.150 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 1752 | 0.150 |
Why?
|
| Blood Proteins | 2 | 2014 | 1191 | 0.150 |
Why?
|
| Depression | 2 | 2018 | 8231 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 1998 | 163 | 0.140 |
Why?
|
| Neoplasms | 4 | 2015 | 22389 | 0.140 |
Why?
|
| Exercise | 7 | 2022 | 5954 | 0.140 |
Why?
|
| omega-N-Methylarginine | 1 | 2017 | 108 | 0.140 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2017 | 30 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
| Body Weights and Measures | 2 | 2018 | 208 | 0.140 |
Why?
|
| Young Adult | 20 | 2016 | 60131 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2010 | 313 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 36854 | 0.140 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2015 | 1751 | 0.140 |
Why?
|
| Particulate Matter | 3 | 2017 | 2615 | 0.140 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 948 | 0.140 |
Why?
|
| Linkage Disequilibrium | 8 | 2016 | 2000 | 0.140 |
Why?
|
| Mass Spectrometry | 4 | 2017 | 2204 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2014 | 2911 | 0.140 |
Why?
|
| Environmental Exposure | 3 | 2017 | 4544 | 0.130 |
Why?
|
| Apolipoprotein C-I | 1 | 2016 | 14 | 0.130 |
Why?
|
| Histidine | 1 | 2017 | 302 | 0.130 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2016 | 40 | 0.130 |
Why?
|
| Leukocytes | 2 | 2017 | 2034 | 0.130 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2017 | 111 | 0.130 |
Why?
|
| Animals | 26 | 2019 | 169335 | 0.130 |
Why?
|
| Vehicle Emissions | 2 | 2017 | 651 | 0.130 |
Why?
|
| Thorax | 2 | 2009 | 557 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Kidney Medulla | 1 | 2015 | 169 | 0.120 |
Why?
|
| Nutrition Assessment | 3 | 2014 | 740 | 0.120 |
Why?
|
| Thyroid Function Tests | 1 | 2016 | 289 | 0.120 |
Why?
|
| Iliac Artery | 1 | 2017 | 344 | 0.120 |
Why?
|
| Blood Pressure Determination | 2 | 2011 | 646 | 0.120 |
Why?
|
| Biotransformation | 1 | 2015 | 166 | 0.120 |
Why?
|
| Electrocardiography | 7 | 2014 | 6413 | 0.120 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.120 |
Why?
|
| Membrane Proteins | 8 | 2014 | 7885 | 0.120 |
Why?
|
| Urinalysis | 1 | 2017 | 370 | 0.120 |
Why?
|
| Hypolipidemic Agents | 3 | 2018 | 609 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2016 | 526 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 458 | 0.120 |
Why?
|
| Renin | 3 | 2015 | 648 | 0.120 |
Why?
|
| Organic Anion Transporters | 2 | 2014 | 101 | 0.120 |
Why?
|
| Receptors, Leptin | 1 | 2016 | 352 | 0.120 |
Why?
|
| Human Genome Project | 1 | 2015 | 202 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 250 | 0.120 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2014 | 57 | 0.120 |
Why?
|
| Environment | 2 | 2008 | 1122 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2010 | 8094 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2013 | 1232 | 0.110 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 294 | 0.110 |
Why?
|
| Heart | 6 | 2014 | 4447 | 0.110 |
Why?
|
| Hypertension, Renal | 1 | 2014 | 135 | 0.110 |
Why?
|
| Nephrolithiasis | 1 | 2015 | 117 | 0.110 |
Why?
|
| Survival Rate | 6 | 2013 | 12873 | 0.110 |
Why?
|
| Milk | 2 | 2015 | 438 | 0.110 |
Why?
|
| Health Priorities | 1 | 2017 | 380 | 0.110 |
Why?
|
| Choristoma | 1 | 2015 | 205 | 0.110 |
Why?
|
| Physical Chromosome Mapping | 1 | 2014 | 183 | 0.110 |
Why?
|
| Netherlands | 2 | 2009 | 2277 | 0.110 |
Why?
|
| Insurance Claim Reporting | 1 | 2014 | 166 | 0.110 |
Why?
|
| Atrial Function | 1 | 2014 | 98 | 0.110 |
Why?
|
| Alpha-Globulins | 1 | 2013 | 26 | 0.110 |
Why?
|
| Neurofibrillary Tangles | 1 | 2016 | 459 | 0.110 |
Why?
|
| Preventive Medicine | 1 | 2015 | 246 | 0.110 |
Why?
|
| Heart Function Tests | 2 | 2011 | 317 | 0.110 |
Why?
|
| Plasma | 1 | 2017 | 585 | 0.110 |
Why?
|
| Kidney Tubules | 1 | 2015 | 454 | 0.110 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2013 | 32 | 0.110 |
Why?
|
| Survival | 1 | 2014 | 160 | 0.110 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 417 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 1340 | 0.110 |
Why?
|
| Glycine | 1 | 2017 | 672 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2005 | 453 | 0.110 |
Why?
|
| Aftercare | 1 | 2019 | 921 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 45 | 0.110 |
Why?
|
| Tunica Media | 2 | 2004 | 111 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2013 | 534 | 0.110 |
Why?
|
| Alcohol Drinking | 4 | 2015 | 4045 | 0.110 |
Why?
|
| Lipodystrophy | 1 | 2014 | 145 | 0.110 |
Why?
|
| Mobility Limitation | 2 | 2016 | 409 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 328 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2013 | 76 | 0.100 |
Why?
|
| Erythropoiesis | 1 | 2016 | 693 | 0.100 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 1891 | 0.100 |
Why?
|
| Walking | 2 | 2017 | 1201 | 0.100 |
Why?
|
| Blood Flow Velocity | 4 | 2009 | 1376 | 0.100 |
Why?
|
| Mortality | 3 | 2017 | 2914 | 0.100 |
Why?
|
| Patient Education as Topic | 3 | 2008 | 2339 | 0.100 |
Why?
|
| Radiography, Abdominal | 1 | 2015 | 541 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2018 | 971 | 0.100 |
Why?
|
| Lysophospholipase | 1 | 2012 | 66 | 0.100 |
Why?
|
| Lysine | 1 | 2017 | 1000 | 0.100 |
Why?
|
| Heart Conduction System | 2 | 2016 | 1009 | 0.100 |
Why?
|
| State Medicine | 1 | 2014 | 219 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2017 | 1550 | 0.100 |
Why?
|
| Glucose Tolerance Test | 6 | 2012 | 1183 | 0.100 |
Why?
|
| Adipose Tissue, White | 2 | 2018 | 371 | 0.100 |
Why?
|
| Lipoproteins, HDL | 3 | 2014 | 682 | 0.100 |
Why?
|
| Caspase 9 | 1 | 2012 | 184 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 712 | 0.100 |
Why?
|
| ROC Curve | 4 | 2014 | 3629 | 0.100 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2017 | 1040 | 0.100 |
Why?
|
| Apolipoproteins B | 1 | 1993 | 386 | 0.100 |
Why?
|
| Cholesterol, LDL | 5 | 2015 | 2403 | 0.090 |
Why?
|
| Authorship | 1 | 2014 | 289 | 0.090 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2011 | 61 | 0.090 |
Why?
|
| Cardiovascular Agents | 2 | 2015 | 849 | 0.090 |
Why?
|
| Computational Biology | 4 | 2017 | 3562 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2015 | 5323 | 0.090 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 1945 | 0.090 |
Why?
|
| Aortic Aneurysm | 2 | 2013 | 649 | 0.090 |
Why?
|
| Receptor, TIE-2 | 1 | 2011 | 183 | 0.090 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2011 | 91 | 0.090 |
Why?
|
| Cell Count | 1 | 2015 | 1833 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 2007 | 279 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 3 | 2013 | 899 | 0.090 |
Why?
|
| Mexico | 5 | 2000 | 769 | 0.090 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 292 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 492 | 0.090 |
Why?
|
| Muscles | 1 | 2015 | 1582 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2003 | 2057 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 11230 | 0.090 |
Why?
|
| Morbidity | 2 | 2008 | 1757 | 0.090 |
Why?
|
| Pedigree | 4 | 2012 | 4545 | 0.090 |
Why?
|
| Genetics, Population | 3 | 2014 | 944 | 0.090 |
Why?
|
| Africa | 3 | 2021 | 726 | 0.090 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2010 | 44 | 0.090 |
Why?
|
| New England | 1 | 2013 | 1058 | 0.090 |
Why?
|
| Homozygote | 1 | 2015 | 1780 | 0.090 |
Why?
|
| DNA Copy Number Variations | 3 | 2014 | 2055 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2010 | 737 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 137 | 0.090 |
Why?
|
| Survival Analysis | 5 | 2014 | 10115 | 0.090 |
Why?
|
| Systems Biology | 1 | 2014 | 482 | 0.090 |
Why?
|
| Random Allocation | 1 | 2014 | 2394 | 0.090 |
Why?
|
| Enzymes | 1 | 2011 | 254 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 1803 | 0.090 |
Why?
|
| Cadherins | 1 | 2014 | 906 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2013 | 652 | 0.080 |
Why?
|
| Heart Failure | 6 | 2017 | 11879 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2011 | 303 | 0.080 |
Why?
|
| Vitamin K | 1 | 2012 | 314 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 4413 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 123 | 0.080 |
Why?
|
| Calcium, Dietary | 1 | 2012 | 533 | 0.080 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 344 | 0.080 |
Why?
|
| Mice | 11 | 2016 | 82072 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2010 | 179 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 710 | 0.080 |
Why?
|
| Gene Expression Profiling | 5 | 2018 | 9549 | 0.080 |
Why?
|
| Parity | 1 | 2012 | 931 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 558 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Adult Children | 2 | 2013 | 104 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 663 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 385 | 0.080 |
Why?
|
| Treatment Outcome | 12 | 2016 | 65480 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2862 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2012 | 1162 | 0.080 |
Why?
|
| Publishing | 1 | 2016 | 837 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 326 | 0.080 |
Why?
|
| Self Report | 2 | 2018 | 3773 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2016 | 2360 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2011 | 3232 | 0.080 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 664 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2010 | 321 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 792 | 0.080 |
Why?
|
| Databases, Genetic | 5 | 2014 | 1758 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 664 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1194 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1904 | 0.080 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2009 | 182 | 0.080 |
Why?
|
| Pulsatile Flow | 1 | 2009 | 320 | 0.080 |
Why?
|
| Ultrasonography | 5 | 2006 | 6002 | 0.080 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2241 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2009 | 348 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2013 | 960 | 0.070 |
Why?
|
| Gait | 1 | 2013 | 822 | 0.070 |
Why?
|
| Aromatase | 1 | 2008 | 147 | 0.070 |
Why?
|
| Cost of Illness | 2 | 2008 | 1960 | 0.070 |
Why?
|
| Pyrophosphatases | 1 | 2008 | 142 | 0.070 |
Why?
|
| Myocardium | 2 | 2011 | 4790 | 0.070 |
Why?
|
| Motivation | 1 | 2017 | 2025 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 348 | 0.070 |
Why?
|
| Causality | 2 | 2011 | 1256 | 0.070 |
Why?
|
| Epidemiology | 1 | 2010 | 278 | 0.070 |
Why?
|
| Glycemic Index | 1 | 2010 | 400 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4356 | 0.070 |
Why?
|
| Epididymis | 1 | 1989 | 227 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 2 | 2006 | 463 | 0.070 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2008 | 241 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2008 | 171 | 0.070 |
Why?
|
| Genetic Testing | 3 | 2017 | 3591 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 677 | 0.070 |
Why?
|
| Osmolar Concentration | 2 | 2017 | 657 | 0.070 |
Why?
|
| Magnesium | 1 | 2010 | 816 | 0.070 |
Why?
|
| Retroviridae | 1 | 1989 | 849 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2017 | 12174 | 0.070 |
Why?
|
| Models, Biological | 7 | 2015 | 9499 | 0.070 |
Why?
|
| DNA Helicases | 1 | 2012 | 854 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3253 | 0.070 |
Why?
|
| Hyperemia | 1 | 2008 | 224 | 0.070 |
Why?
|
| Tomography | 1 | 2009 | 442 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2537 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 6547 | 0.070 |
Why?
|
| Exons | 1 | 2012 | 2395 | 0.070 |
Why?
|
| Heart Rate | 1 | 2018 | 4217 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2018 | 2192 | 0.070 |
Why?
|
| Potassium | 1 | 2010 | 1315 | 0.060 |
Why?
|
| Social Support | 1 | 2016 | 2193 | 0.060 |
Why?
|
| Adolescent | 14 | 2015 | 89244 | 0.060 |
Why?
|
| Ankle | 2 | 2006 | 353 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 4076 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2009 | 892 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 1568 | 0.060 |
Why?
|
| Sclerosis | 1 | 2005 | 212 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 1304 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2009 | 829 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2005 | 127 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 1262 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 749 | 0.060 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 3 | 2010 | 153 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 1724 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4528 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 873 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 361 | 0.060 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 2027 | 0.060 |
Why?
|
| Arteries | 3 | 2007 | 1126 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 10400 | 0.060 |
Why?
|
| Morphine | 1 | 2008 | 658 | 0.060 |
Why?
|
| Air Pollution | 1 | 2017 | 2372 | 0.060 |
Why?
|
| Age of Onset | 2 | 2008 | 3346 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 990 | 0.060 |
Why?
|
| Apolipoproteins | 1 | 2006 | 328 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 7609 | 0.050 |
Why?
|
| Informed Consent | 1 | 2010 | 1010 | 0.050 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 368 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 606 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 2034 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 544 | 0.050 |
Why?
|
| Diuretics | 1 | 2006 | 614 | 0.050 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 1461 | 0.050 |
Why?
|
| Outpatients | 1 | 2011 | 1603 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1891 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1321 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2012 | 2323 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2009 | 1531 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2013 | 2590 | 0.050 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1056 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 22379 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2017 | 5622 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2011 | 3466 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 640 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3713 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2015 | 42683 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 569 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2017 | 4432 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2015 | 527 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 802 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 1133 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 371 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2452 | 0.050 |
Why?
|
| Mental Recall | 1 | 2008 | 1226 | 0.050 |
Why?
|
| Lung Volume Measurements | 2 | 2015 | 381 | 0.050 |
Why?
|
| Social Class | 1 | 2011 | 2009 | 0.050 |
Why?
|
| Heart Ventricles | 3 | 2010 | 3840 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1418 | 0.050 |
Why?
|
| Carotid Stenosis | 2 | 2006 | 862 | 0.050 |
Why?
|
| Brain | 3 | 2016 | 27453 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 165 | 0.050 |
Why?
|
| Mutation, Missense | 4 | 2013 | 2592 | 0.050 |
Why?
|
| Vaginitis | 1 | 2001 | 50 | 0.050 |
Why?
|
| Stem Cells | 2 | 2013 | 3539 | 0.050 |
Why?
|
| Testosterone | 2 | 2011 | 2493 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2013 | 2085 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 8748 | 0.050 |
Why?
|
| Child | 12 | 2015 | 80960 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 2913 | 0.050 |
Why?
|
| Health Policy | 1 | 2013 | 2700 | 0.050 |
Why?
|
| Patient Selection | 3 | 2009 | 4265 | 0.050 |
Why?
|
| Breast Feeding | 1 | 2009 | 1364 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2009 | 1060 | 0.050 |
Why?
|
| Family | 3 | 2010 | 3208 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2016 | 997 | 0.040 |
Why?
|
| Estradiol | 1 | 2008 | 1952 | 0.040 |
Why?
|
| Leisure Activities | 1 | 2022 | 310 | 0.040 |
Why?
|
| HIV-1 | 4 | 2001 | 6962 | 0.040 |
Why?
|
| Insulin, Long-Acting | 1 | 2000 | 59 | 0.040 |
Why?
|
| Environmental Monitoring | 2 | 2017 | 1469 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2744 | 0.040 |
Why?
|
| Lung | 2 | 2010 | 10099 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 898 | 0.040 |
Why?
|
| Proteomics | 1 | 2014 | 3914 | 0.040 |
Why?
|
| Inpatients | 1 | 2011 | 2569 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 1388 | 0.040 |
Why?
|
| Mycobacterium avium | 1 | 1999 | 30 | 0.040 |
Why?
|
| Cholesterol | 1 | 2009 | 2913 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4479 | 0.040 |
Why?
|
| Mutation | 3 | 2014 | 30266 | 0.040 |
Why?
|
| RNA, Viral | 3 | 2001 | 2871 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3608 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2004 | 975 | 0.040 |
Why?
|
| Celiac Disease | 1 | 2007 | 820 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 4794 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 286 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2194 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 877 | 0.040 |
Why?
|
| Hospitalization | 2 | 2010 | 10847 | 0.040 |
Why?
|
| Calorimetry, Indirect | 1 | 1998 | 176 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2017 | 128 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 9618 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 1789 | 0.040 |
Why?
|
| Virus Activation | 1 | 1999 | 324 | 0.040 |
Why?
|
| Pregnancy | 2 | 2012 | 30265 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 3941 | 0.030 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 3836 | 0.030 |
Why?
|
| Hypoglycemic Agents | 4 | 2018 | 3110 | 0.030 |
Why?
|
| Sulfates | 1 | 2017 | 379 | 0.030 |
Why?
|
| Patient Admission | 1 | 2004 | 1370 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2010 | 3491 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 2015 | 2905 | 0.030 |
Why?
|
| Cathepsin C | 1 | 2015 | 4 | 0.030 |
Why?
|
| Soot | 1 | 2017 | 219 | 0.030 |
Why?
|
| Disease Susceptibility | 3 | 2007 | 1794 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 6888 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 163 | 0.030 |
Why?
|
| Heart Valves | 1 | 2017 | 284 | 0.030 |
Why?
|
| Mass Screening | 2 | 2007 | 5457 | 0.030 |
Why?
|
| Monosaccharides | 1 | 2015 | 64 | 0.030 |
Why?
|
| Vagina | 1 | 2001 | 849 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2014 | 23653 | 0.030 |
Why?
|
| Educational Status | 2 | 2015 | 2515 | 0.030 |
Why?
|
| Gene Expression | 3 | 2014 | 7603 | 0.030 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 354 | 0.030 |
Why?
|
| Nuclear Family | 2 | 2007 | 311 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2015 | 150 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3811 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 353 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8760 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 1769 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2014 | 2732 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 2 | 2009 | 877 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 358 | 0.030 |
Why?
|
| Ozone | 1 | 2017 | 496 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 247 | 0.030 |
Why?
|
| Independent Living | 1 | 2018 | 584 | 0.030 |
Why?
|
| Cell Line | 4 | 2013 | 15604 | 0.030 |
Why?
|
| Spouses | 1 | 2016 | 286 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2013 | 1970 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 7861 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2012 | 27 | 0.030 |
Why?
|
| Sepsis | 1 | 2007 | 2610 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 859 | 0.030 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 88 | 0.030 |
Why?
|
| Housing | 1 | 2017 | 683 | 0.030 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2013 | 78 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 1993 | 157 | 0.030 |
Why?
|
| Purinergic Antagonists | 1 | 1992 | 10 | 0.030 |
Why?
|
| Lipoproteins, LDL | 2 | 2014 | 643 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 808 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2013 | 158 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 290 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2013 | 206 | 0.030 |
Why?
|
| Xanthines | 1 | 1992 | 121 | 0.020 |
Why?
|
| Inhibins | 1 | 2012 | 210 | 0.020 |
Why?
|
| Goals | 1 | 2017 | 717 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 213 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2017 | 812 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1995 | 668 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 3838 | 0.020 |
Why?
|
| Diet Records | 1 | 2013 | 426 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 299 | 0.020 |
Why?
|
| Neurocan | 1 | 2011 | 21 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 1997 | 819 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 271 | 0.020 |
Why?
|
| Drosophila | 1 | 2019 | 1513 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2011 | 41 | 0.020 |
Why?
|
| Epigenomics | 1 | 2017 | 961 | 0.020 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 36 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 385 | 0.020 |
Why?
|
| Epithelium | 2 | 2001 | 1607 | 0.020 |
Why?
|
| Social Mobility | 1 | 2011 | 30 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12806 | 0.020 |
Why?
|
| Interleukin-11 | 1 | 2010 | 59 | 0.020 |
Why?
|
| Locomotion | 1 | 2013 | 388 | 0.020 |
Why?
|
| San Francisco | 1 | 2011 | 166 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2011 | 142 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| North America | 1 | 2014 | 1290 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 166 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Proteinuria | 1 | 2013 | 610 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1831 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 3235 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 630 | 0.020 |
Why?
|
| Finland | 1 | 2011 | 609 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Fiducial Markers | 1 | 2011 | 134 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 223 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9377 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2013 | 652 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 390 | 0.020 |
Why?
|
| Arizona | 2 | 2000 | 108 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2014 | 1645 | 0.020 |
Why?
|
| Nucleotides | 1 | 2012 | 455 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 323 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1077 | 0.020 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2010 | 108 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1124 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 174 | 0.020 |
Why?
|
| Chlorides | 1 | 1992 | 666 | 0.020 |
Why?
|
| Albumins | 1 | 2012 | 577 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2011 | 2714 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 1351 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 677 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 5864 | 0.020 |
Why?
|
| Ribosomes | 1 | 2012 | 499 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2013 | 556 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2017 | 1068 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 473 | 0.020 |
Why?
|
| California | 1 | 1993 | 1443 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1191 | 0.020 |
Why?
|
| Glutamine | 1 | 2012 | 578 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2010 | 508 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 515 | 0.020 |
Why?
|
| Ireland | 1 | 2009 | 170 | 0.020 |
Why?
|
| Lipase | 1 | 2011 | 321 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2085 | 0.020 |
Why?
|
| Meperidine | 1 | 2008 | 37 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 1379 | 0.020 |
Why?
|
| Sufentanil | 1 | 2008 | 42 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2016 | 1839 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Ornithine | 1 | 2008 | 79 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2011 | 268 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 402 | 0.020 |
Why?
|
| Occupations | 1 | 2011 | 516 | 0.020 |
Why?
|
| Rats | 2 | 2015 | 23786 | 0.020 |
Why?
|
| Cohort Effect | 1 | 2008 | 39 | 0.020 |
Why?
|
| Diphenhydramine | 1 | 2008 | 63 | 0.020 |
Why?
|
| Echocardiography | 2 | 2011 | 5047 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1082 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 848 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 1999 | 247 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2016 | 1163 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 1996 | 3473 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 746 | 0.020 |
Why?
|
| HIV Infections | 4 | 2001 | 17591 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 2423 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1371 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5434 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 593 | 0.020 |
Why?
|
| Glyburide | 1 | 2008 | 117 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2011 | 796 | 0.020 |
Why?
|
| Morus | 1 | 2007 | 2 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2121 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 776 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2009 | 325 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2001 | 2598 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2010 | 838 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
| Cytophotometry | 1 | 1987 | 8 | 0.020 |
Why?
|
| Adenosine | 1 | 1992 | 822 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2011 | 779 | 0.020 |
Why?
|
| Biopsy | 2 | 2016 | 6805 | 0.020 |
Why?
|
| Northern Ireland | 1 | 2007 | 37 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2007 | 157 | 0.020 |
Why?
|
| Dinoprost | 1 | 2007 | 139 | 0.020 |
Why?
|
| Sunlight | 1 | 2009 | 337 | 0.020 |
Why?
|
| Ethanol | 1 | 2013 | 1331 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6023 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2360 | 0.020 |
Why?
|
| Physicians | 1 | 2005 | 4607 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 937 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 157 | 0.020 |
Why?
|
| Cats | 1 | 2008 | 978 | 0.020 |
Why?
|
| Population Groups | 1 | 2008 | 208 | 0.020 |
Why?
|
| Diastole | 1 | 2009 | 785 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1726 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2007 | 85 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 785 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2006 | 151 | 0.020 |
Why?
|
| Hypoglycemia | 2 | 2006 | 895 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2007 | 248 | 0.020 |
Why?
|
| Tuberculosis | 1 | 1999 | 2029 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 5801 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1992 | 1209 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2013 | 1245 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 1647 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 2560 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4862 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1222 | 0.020 |
Why?
|
| Apolipoproteins A | 1 | 2006 | 96 | 0.020 |
Why?
|
| Radiation Pneumonitis | 1 | 2006 | 100 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2006 | 133 | 0.020 |
Why?
|
| Naloxone | 1 | 2008 | 372 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2008 | 744 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1764 | 0.020 |
Why?
|
| Cell Size | 1 | 2007 | 626 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2094 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2006 | 277 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10765 | 0.020 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2006 | 113 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2007 | 13594 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 1989 | 506 | 0.010 |
Why?
|
| Phytotherapy | 1 | 2007 | 298 | 0.010 |
Why?
|
| Fentanyl | 1 | 2008 | 450 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 411 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2013 | 1305 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1536 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1197 | 0.010 |
Why?
|
| Nursing Diagnosis | 1 | 2004 | 16 | 0.010 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2011 | 812 | 0.010 |
Why?
|
| Glutens | 1 | 2007 | 240 | 0.010 |
Why?
|
| HIV | 1 | 1991 | 1597 | 0.010 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 167 | 0.010 |
Why?
|
| Androgens | 1 | 2011 | 1285 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1680 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1742 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 1092 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2008 | 1418 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2007 | 487 | 0.010 |
Why?
|
| Injections | 1 | 2006 | 841 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2009 | 565 | 0.010 |
Why?
|
| Monocytes | 1 | 2013 | 2603 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2007 | 499 | 0.010 |
Why?
|
| Hemostasis | 1 | 2006 | 468 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2187 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1992 | 1295 | 0.010 |
Why?
|
| Caffeine | 1 | 2007 | 703 | 0.010 |
Why?
|
| England | 1 | 2004 | 533 | 0.010 |
Why?
|
| Viremia | 2 | 1996 | 725 | 0.010 |
Why?
|
| Placebos | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 9080 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 947 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 983 | 0.010 |
Why?
|
| Base Sequence | 1 | 1993 | 12430 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2009 | 4064 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3968 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2010 | 1423 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 3612 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 680 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 2080 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1902 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2012 | 2986 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2009 | 2614 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4148 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 8055 | 0.010 |
Why?
|
| Minority Groups | 1 | 2008 | 1216 | 0.010 |
Why?
|
| Patient Participation | 1 | 2010 | 1448 | 0.010 |
Why?
|
| Fertility | 1 | 2005 | 771 | 0.010 |
Why?
|
| Dyspnea | 1 | 1989 | 1352 | 0.010 |
Why?
|
| Physical Examination | 1 | 2007 | 1262 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 2001 | 169 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14484 | 0.010 |
Why?
|
| Thailand | 1 | 2001 | 288 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17629 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2431 | 0.010 |
Why?
|
| Bone Density | 1 | 2013 | 3574 | 0.010 |
Why?
|
| Cisplatin | 1 | 2006 | 1661 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 2203 | 0.010 |
Why?
|
| Toxoplasmosis, Animal | 1 | 1999 | 19 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2812 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3443 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1667 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2006 | 2921 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2008 | 2025 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8513 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2007 | 734 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 1999 | 317 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2014 | 3463 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2011 | 5151 | 0.010 |
Why?
|
| Self Care | 1 | 2004 | 801 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 11262 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 4199 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1981 | 0.010 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 1978 | 33 | 0.010 |
Why?
|
| Infant | 3 | 2008 | 36556 | 0.010 |
Why?
|
| Toxoplasma | 1 | 1999 | 159 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1987 | 2885 | 0.010 |
Why?
|
| Virus Replication | 2 | 1999 | 2458 | 0.010 |
Why?
|
| Research Design | 1 | 2014 | 6214 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2011 | 6291 | 0.010 |
Why?
|
| Northwestern United States | 1 | 1997 | 20 | 0.010 |
Why?
|
| Alaska | 1 | 1997 | 68 | 0.010 |
Why?
|
| Virion | 1 | 1999 | 430 | 0.010 |
Why?
|
| Seat Belts | 1 | 1997 | 60 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18354 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3592 | 0.010 |
Why?
|
| HIV Seropositivity | 2 | 1995 | 967 | 0.010 |
Why?
|
| Didanosine | 1 | 1996 | 151 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2011 | 4850 | 0.010 |
Why?
|
| Nevirapine | 1 | 1996 | 273 | 0.010 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2001 | 668 | 0.010 |
Why?
|
| Cholestasis | 1 | 1978 | 385 | 0.010 |
Why?
|
| Zidovudine | 1 | 1996 | 625 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8559 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2108 | 0.010 |
Why?
|
| Communication | 1 | 2008 | 3908 | 0.010 |
Why?
|
| Cineangiography | 1 | 1973 | 108 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 2294 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1978 | 880 | 0.010 |
Why?
|
| 2-Chloroadenosine | 1 | 1992 | 11 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1904 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1987 | 2931 | 0.010 |
Why?
|
| Viral Load | 1 | 2001 | 3398 | 0.010 |
Why?
|
| Progestins | 1 | 1992 | 302 | 0.010 |
Why?
|
| Melanoma | 1 | 2009 | 5709 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1991 | 381 | 0.010 |
Why?
|
| Autopsy | 1 | 1973 | 1013 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1996 | 2205 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2004 | 4056 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1992 | 453 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 2593 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 6982 | 0.000 |
Why?
|
| Perfusion | 1 | 1973 | 1402 | 0.000 |
Why?
|
| Catheterization | 1 | 1973 | 1431 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1995 | 1855 | 0.000 |
Why?
|
| Estrogens | 1 | 1995 | 1536 | 0.000 |
Why?
|
| HIV Antibodies | 1 | 1995 | 1341 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1390 | 0.000 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1989 | 242 | 0.000 |
Why?
|
| Heart Block | 1 | 1949 | 390 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9565 | 0.000 |
Why?
|
| Urban Population | 1 | 1995 | 2046 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26428 | 0.000 |
Why?
|
| Ploidies | 1 | 1987 | 287 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 6320 | 0.000 |
Why?
|
| Ventricular Fibrillation | 1 | 1949 | 537 | 0.000 |
Why?
|
| Cerebrovascular Disorders | 1 | 1992 | 1486 | 0.000 |
Why?
|
| Kinetics | 1 | 1992 | 6332 | 0.000 |
Why?
|
| Pyridines | 1 | 1996 | 2895 | 0.000 |
Why?
|
| Macrophages | 1 | 1999 | 5801 | 0.000 |
Why?
|
| Hip Fractures | 1 | 1992 | 997 | 0.000 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 21188 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3070 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1999 | 19023 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 13698 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1992 | 1386 | 0.000 |
Why?
|
| Poverty | 1 | 1995 | 2720 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1987 | 1748 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1992 | 2543 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1949 | 2258 | 0.000 |
Why?
|
| Lipoproteins, VLDL | 1 | 1978 | 201 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 6401 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1992 | 5443 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 9264 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 13021 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1987 | 11886 | 0.000 |
Why?
|